Praxis Precision Medicines
PRAX
#2234
Rank
$8.07 B
Marketcap
$290.10
Share price
-4.16%
Change (1 day)
646.72%
Change (1 year)

Revenue for Praxis Precision Medicines (PRAX)

Revenue in 2025 (TTM): N/A

a decrease over the revenue in the year 2024 that were of $8.55 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Praxis Precision Medicines from 2020 to 2025

Annual revenue

Year Revenue Change
2025 N/A-100%
2024 $8.55 M249.53%
2023 $2.44 M
2022 N/A
2021 N/A
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA